Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Dr R Klaus Veitinger > Profile

Dr R Klaus Veitinger

Affiliations

at Scpharmaceuticals Inc. (SCPH), 2025-06-05
Director at Tricida Inc. (TCDA), 2022-06-16
Director at Intercept Pharmaceuticals Inc (ICPT), 2015-11-28
Director at Relypsa Inc (RLYP), 2015-05-13

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
TCDA	$38.87	1,750	$68,022.50	51,444	2019-11-01	Filing
TCDA	$38.88	1,750	$68,040.00	51,444	2019-11-01	Filing
TCDA	$38.88	1,750	$68,040.00	41,315	2019-11-01	Filing
TCDA	$36.29	1,750	$63,507.50	53,194	2019-10-25	Filing
TCDA	$36.30	1,750	$63,525.00	53,194	2019-10-25	Filing